Pathophysiology of Eosinophilic Esophagitis

Kelly M. O'Shea, Seema S. Aceves, Evan S. Dellon, Sandeep Gupta, Jonathan M. Spergel, Glenn T. Furuta, Marc E. Rothenberg

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Eosinophilic esophagitis is an emerging disease that is distinguished from gastroesophageal reflux disease by the expression of a unique esophageal transcriptome and the interplay of early life environmental factors with distinct genetic susceptibility elements at 5q22 (TSLP) and 2p23 (CAPN14). Rare genetic syndromes have uncovered the contribution of barrier disruption, mediated in part by defective desmosomes and dysregulated transforming growth factor beta production and signaling, to eosinophilic esophagitis pathophysiology. Experimental modeling has defined a cooperative role of activated eosinophils, mast cells, and the cytokines IL-5 and IL-13, mediated by allergic sensitization to multiple foods. Understanding these processes is opening the way to better treatment based on disrupting allergic inflammatory and type 2 cytokine–mediated responses, including anti-cytokine therapeutics and dietary therapy.

Original languageEnglish (US)
Pages (from-to)333-345
Number of pages13
JournalGastroenterology
Volume154
Issue number2
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Eosinophilic Esophagitis
Cytokines
Desmosomes
Interleukin-13
Interleukin-5
Genetic Predisposition to Disease
Gastroesophageal Reflux
Transcriptome
Eosinophils
Mast Cells
Transforming Growth Factor beta
Therapeutics
Food

Keywords

  • Allergy
  • Desmosome
  • Genetics
  • Inflammation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

O'Shea, K. M., Aceves, S. S., Dellon, E. S., Gupta, S., Spergel, J. M., Furuta, G. T., & Rothenberg, M. E. (2018). Pathophysiology of Eosinophilic Esophagitis. Gastroenterology, 154(2), 333-345. https://doi.org/10.1053/j.gastro.2017.06.065

Pathophysiology of Eosinophilic Esophagitis. / O'Shea, Kelly M.; Aceves, Seema S.; Dellon, Evan S.; Gupta, Sandeep; Spergel, Jonathan M.; Furuta, Glenn T.; Rothenberg, Marc E.

In: Gastroenterology, Vol. 154, No. 2, 01.01.2018, p. 333-345.

Research output: Contribution to journalArticle

O'Shea, KM, Aceves, SS, Dellon, ES, Gupta, S, Spergel, JM, Furuta, GT & Rothenberg, ME 2018, 'Pathophysiology of Eosinophilic Esophagitis', Gastroenterology, vol. 154, no. 2, pp. 333-345. https://doi.org/10.1053/j.gastro.2017.06.065
O'Shea KM, Aceves SS, Dellon ES, Gupta S, Spergel JM, Furuta GT et al. Pathophysiology of Eosinophilic Esophagitis. Gastroenterology. 2018 Jan 1;154(2):333-345. https://doi.org/10.1053/j.gastro.2017.06.065
O'Shea, Kelly M. ; Aceves, Seema S. ; Dellon, Evan S. ; Gupta, Sandeep ; Spergel, Jonathan M. ; Furuta, Glenn T. ; Rothenberg, Marc E. / Pathophysiology of Eosinophilic Esophagitis. In: Gastroenterology. 2018 ; Vol. 154, No. 2. pp. 333-345.
@article{3c46f61e3d5843f8902def1c307771ef,
title = "Pathophysiology of Eosinophilic Esophagitis",
abstract = "Eosinophilic esophagitis is an emerging disease that is distinguished from gastroesophageal reflux disease by the expression of a unique esophageal transcriptome and the interplay of early life environmental factors with distinct genetic susceptibility elements at 5q22 (TSLP) and 2p23 (CAPN14). Rare genetic syndromes have uncovered the contribution of barrier disruption, mediated in part by defective desmosomes and dysregulated transforming growth factor beta production and signaling, to eosinophilic esophagitis pathophysiology. Experimental modeling has defined a cooperative role of activated eosinophils, mast cells, and the cytokines IL-5 and IL-13, mediated by allergic sensitization to multiple foods. Understanding these processes is opening the way to better treatment based on disrupting allergic inflammatory and type 2 cytokine–mediated responses, including anti-cytokine therapeutics and dietary therapy.",
keywords = "Allergy, Desmosome, Genetics, Inflammation",
author = "O'Shea, {Kelly M.} and Aceves, {Seema S.} and Dellon, {Evan S.} and Sandeep Gupta and Spergel, {Jonathan M.} and Furuta, {Glenn T.} and Rothenberg, {Marc E.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1053/j.gastro.2017.06.065",
language = "English (US)",
volume = "154",
pages = "333--345",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Pathophysiology of Eosinophilic Esophagitis

AU - O'Shea, Kelly M.

AU - Aceves, Seema S.

AU - Dellon, Evan S.

AU - Gupta, Sandeep

AU - Spergel, Jonathan M.

AU - Furuta, Glenn T.

AU - Rothenberg, Marc E.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Eosinophilic esophagitis is an emerging disease that is distinguished from gastroesophageal reflux disease by the expression of a unique esophageal transcriptome and the interplay of early life environmental factors with distinct genetic susceptibility elements at 5q22 (TSLP) and 2p23 (CAPN14). Rare genetic syndromes have uncovered the contribution of barrier disruption, mediated in part by defective desmosomes and dysregulated transforming growth factor beta production and signaling, to eosinophilic esophagitis pathophysiology. Experimental modeling has defined a cooperative role of activated eosinophils, mast cells, and the cytokines IL-5 and IL-13, mediated by allergic sensitization to multiple foods. Understanding these processes is opening the way to better treatment based on disrupting allergic inflammatory and type 2 cytokine–mediated responses, including anti-cytokine therapeutics and dietary therapy.

AB - Eosinophilic esophagitis is an emerging disease that is distinguished from gastroesophageal reflux disease by the expression of a unique esophageal transcriptome and the interplay of early life environmental factors with distinct genetic susceptibility elements at 5q22 (TSLP) and 2p23 (CAPN14). Rare genetic syndromes have uncovered the contribution of barrier disruption, mediated in part by defective desmosomes and dysregulated transforming growth factor beta production and signaling, to eosinophilic esophagitis pathophysiology. Experimental modeling has defined a cooperative role of activated eosinophils, mast cells, and the cytokines IL-5 and IL-13, mediated by allergic sensitization to multiple foods. Understanding these processes is opening the way to better treatment based on disrupting allergic inflammatory and type 2 cytokine–mediated responses, including anti-cytokine therapeutics and dietary therapy.

KW - Allergy

KW - Desmosome

KW - Genetics

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=85044785670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044785670&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2017.06.065

DO - 10.1053/j.gastro.2017.06.065

M3 - Article

C2 - 28757265

AN - SCOPUS:85044785670

VL - 154

SP - 333

EP - 345

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 2

ER -